 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval( g9 w L& V& C4 j6 h$ Q% b
0 x) q$ C3 b# e) |5 }EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX., {, T. |5 y$ D* n8 b0 y, B. \" K
: C/ r8 x7 Y: w& z8 {9 Y" a
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
2 z' I; c5 W$ G( Q! H2 V4 }
8 C" _" W5 h: l9 B1 D" n9 h5 Z ' [' L( Z( e) n" q6 H3 {3 `: V
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
5 R) H/ R8 q7 z+ ^: s3 m5 ^: f( X8 S0 O6 X
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."4 ~- C# x9 j. K! j9 Q J8 p
% G# I8 e; u$ V3 S' I: r+ ?
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.5 K" {% u% b$ p" _8 z
+ n$ u* ~" V! \9 M8 V6 aIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
( F! h& p6 T) H$ {7 l; l, w* V% L# j
8 m) d/ a0 N1 T/ BIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
. e, [& P; O" Z% |# P3 X
e; h7 C2 S! A. x: r; E1 E"As a scientist, it's one of the highlights of my CAREER," Shan said.
3 ^2 p" a% a! q" ^: O
) k, r8 D7 C% q- ^% F; J# @"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
: K% i) l3 S& c% S1 v' o4 m7 Z0 K, W/ m' ~- o! c6 ^8 a
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said., ? h0 t: C) s
5 v( q" l- G8 CGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.0 B; x4 X4 a. j4 H
' ~9 D: @0 f0 Z/ B& `+ a/ t) xThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
/ T- X# A8 Y4 f( G4 f) s0 b+ s8 [5 v) G6 y, t
, V# ~2 e' U& R& [ `. G7 \& k
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
